$LAB
STANDARD BIOTOOLS INC.

2013 Q4 Form 10-Q Financial Statement

#000144530513002845 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $20.88M $18.29M $12.78M
YoY Change 33.35% 43.07% 20.63%
Cost Of Revenue $5.930M $5.138M $3.518M
YoY Change 36.64% 46.05% 6.28%
Gross Profit $14.95M $13.15M $9.264M
YoY Change 32.07% 41.94% 27.08%
Gross Profit Margin 71.6% 71.9% 72.48%
Selling, General & Admin $13.57M $12.10M $9.102M
YoY Change 28.63% 32.9% 13.07%
% of Gross Profit 90.77% 92.0% 98.25%
Research & Development $5.760M $5.004M $4.071M
YoY Change 34.89% 22.92% 23.74%
% of Gross Profit 38.53% 38.06% 43.94%
Depreciation & Amortization $700.0K $660.0K $360.0K
YoY Change -35.78% 83.33% 38.46%
% of Gross Profit 4.68% 5.02% 3.89%
Operating Expenses $19.33M $17.10M $13.17M
YoY Change 30.52% 29.82% 16.16%
Operating Profit -$4.380M -$4.952M -$3.909M
YoY Change 25.5% 26.68% -3.48%
Interest Expense $0.00 $1.000K $107.0K
YoY Change -100.0% -99.07% -124.32%
% of Operating Profit
Other Income/Expense, Net $40.00K $709.0K -$75.00K
YoY Change -166.67% -1045.33% -350.0%
Pretax Income -$4.600M -$4.244M -$4.091M
YoY Change 28.85% 3.74% -8.48%
Income Tax $40.00K $42.00K $61.00K
% Of Pretax Income
Net Earnings -$4.640M -$4.286M -$4.152M
YoY Change 28.89% 3.23% -7.53%
Net Earnings / Revenue -22.22% -23.44% -32.48%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.18 -$0.17 -$0.18
COMMON SHARES
Basic Shares Outstanding 25.61M shares 25.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $84.30M $63.70M $86.20M
YoY Change 5.38% -26.1% 46.35%
Cash & Equivalents $35.26M $20.10M $66.01M
Short-Term Investments $49.10M $43.60M $20.10M
Other Short-Term Assets $1.500M $2.500M $1.500M
YoY Change 36.36% 66.67% -34.78%
Inventory $8.148M $8.021M $7.200M
Prepaid Expenses
Receivables $10.55M $12.41M $10.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $104.6M $86.66M $105.5M
YoY Change 3.33% -17.86% 38.82%
LONG-TERM ASSETS
Property, Plant & Equipment $6.818M $5.155M $4.300M
YoY Change 37.07% 19.88% 65.38%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $1.900M $19.10M $3.200M
YoY Change -48.65% 496.88% 146.15%
Other Assets $3.571M $3.288M $4.000M
YoY Change -7.99% -17.8% 48.15%
Total Long-Term Assets $12.33M $27.58M $11.60M
YoY Change -1.52% 137.78% 75.76%
TOTAL ASSETS
Total Short-Term Assets $104.6M $86.66M $105.5M
Total Long-Term Assets $12.33M $27.58M $11.60M
Total Assets $116.9M $114.2M $117.1M
YoY Change 2.8% -2.44% 41.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.353M $3.406M $3.300M
YoY Change 70.37% 3.21% -29.79%
Accrued Expenses $5.392M $5.117M $5.800M
YoY Change 26.01% -11.78% 26.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $1.900M
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $17.95M $15.04M $13.10M
YoY Change 54.79% 14.83% -33.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $651.0K $362.0K $1.300M
YoY Change 174.68% -72.15% 62.5%
Total Long-Term Liabilities $651.0K $362.0K $1.300M
YoY Change 174.68% -72.15% -65.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.95M $15.04M $13.10M
Total Long-Term Liabilities $651.0K $362.0K $1.300M
Total Liabilities $20.50M $17.23M $14.40M
YoY Change 56.8% 19.65% -38.72%
SHAREHOLDERS EQUITY
Retained Earnings -$257.3M -$252.7M
YoY Change 6.86%
Common Stock $26.00K $26.00K
YoY Change 4.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $96.41M $97.01M $102.7M
YoY Change
Total Liabilities & Shareholders Equity $116.9M $114.2M $117.1M
YoY Change 2.8% -2.44% 41.77%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$4.640M -$4.286M -$4.152M
YoY Change 28.89% 3.23% -7.53%
Depreciation, Depletion And Amortization $700.0K $660.0K $360.0K
YoY Change -35.78% 83.33% 38.46%
Cash From Operating Activities $3.240M -$1.310M -$3.340M
YoY Change -192.57% -60.78% 40.34%
INVESTING ACTIVITIES
Capital Expenditures $2.080M $550.0K $380.0K
YoY Change 173.68% 44.74% 31.03%
Acquisitions
YoY Change
Other Investing Activities $11.69M -$11.51M $5.670M
YoY Change -795.83% -303.0% 9.67%
Cash From Investing Activities $9.610M -$12.06M $5.280M
YoY Change -493.85% -328.41% 7.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $56.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.310M 1.080M 54.12M
YoY Change -261.54% -98.0% -6865.0%
NET CHANGE
Cash From Operating Activities 3.240M -1.310M -3.340M
Cash From Investing Activities 9.610M -12.06M 5.280M
Cash From Financing Activities 2.310M 1.080M 54.12M
Net Change In Cash 15.16M -12.29M 56.06M
YoY Change -305.7% -121.92% 3178.36%
FREE CASH FLOW
Cash From Operating Activities $3.240M -$1.310M -$3.340M
Capital Expenditures $2.080M $550.0K $380.0K
Free Cash Flow $1.160M -$1.860M -$3.720M
YoY Change -127.23% -50.0% 39.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3406000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2555000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12900000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12413000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5117000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4279000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-713000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-769000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
350403000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
342222000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4700000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1700000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3000000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
448000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000 USD
CY2012Q4 us-gaap Assets
Assets
113732000 USD
CY2013Q3 us-gaap Assets
Assets
114241000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
86658000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
101211000 USD
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26596000 USD
CY2013Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
68522000 USD
CY2013Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
43600000 USD
CY2013Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1550000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-978000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1451000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1652000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
502000 USD
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25591000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1344000 USD
CY2012Q4 us-gaap Cash
Cash
57082000 USD
CY2013Q3 us-gaap Cash
Cash
14297000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58649000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20099000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66011000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13553000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
52458000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-38550000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25115000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25115000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25591000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
25000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
26000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4144000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15442000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4204000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11827000 USD
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
1300000 USD
CY2012Q3 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
CY2013Q3 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1777000 USD
CY2013Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1777000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3518000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14273000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5138000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
10990000 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
16691000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
23239000 USD
us-gaap Costs And Expenses
CostsAndExpenses
51253000 USD
us-gaap Costs And Expenses
CostsAndExpenses
64311000 USD
CY2010Q4 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.01
CY2011Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
600000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2807000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1886000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1241000 USD
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1824000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1592000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1850000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1553000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1652000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
175000 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
40000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40000 USD
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3713000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2877000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
16600000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
600000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4091000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15321000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11788000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4244000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
101000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1150000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-572000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
433000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1411000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
1000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
107000 USD
us-gaap Interest Expense
InterestExpense
616000 USD
us-gaap Interest Expense
InterestExpense
13000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2954000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3682000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
8021000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
7169000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2846000 USD
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2536000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1803000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1369000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
13075000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
17229000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4681000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3047000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114241000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113732000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15043000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11597000 USD
CY2012Q3 us-gaap Licenses Revenue
LicensesRevenue
15000 USD
us-gaap Licenses Revenue
LicensesRevenue
242000 USD
CY2013Q3 us-gaap Licenses Revenue
LicensesRevenue
78000 USD
us-gaap Licenses Revenue
LicensesRevenue
53000 USD
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0425
CY2010Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000.0 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
3666000 USD
CY2013Q3 us-gaap Long Term Investments
LongTermInvestments
19140000 USD
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
1000000 USD
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2012Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2013Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
1000000 USD
CY2013Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5802000 USD
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
17000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49953000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3501000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37182000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16444000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4829000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13979000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11883000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-4152000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4286000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15422000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1229000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Operating Income Loss
OperatingIncomeLoss
-14578000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4952000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-14009000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3909000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3288000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3881000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
82000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
56000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
237000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
362000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-26000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-29000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
709000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-75000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
457000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-127000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1043000 USD
CY2013Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1043000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
56831000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27705000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1621000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1565000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1131000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2545000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents.</font></div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56143000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1875000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
19140000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
45770000 USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3117000 USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 USD
CY2013Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3117000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2125000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3501000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5155000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4974000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10190000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5004000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12337000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4071000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14198000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-240821000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252704000 USD
us-gaap Revenue From Grants
RevenueFromGrants
496000 USD
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
165000 USD
us-gaap Revenue From Grants
RevenueFromGrants
494000 USD
CY2013Q3 us-gaap Revenue From Grants
RevenueFromGrants
164000 USD
CY2012Q3 us-gaap Revenues
Revenues
12782000 USD
us-gaap Revenues
Revenues
50302000 USD
CY2013Q3 us-gaap Revenues
Revenues
18287000 USD
us-gaap Revenues
Revenues
36675000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36126000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
49566000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12602000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18045000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34840000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12097000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9102000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27926000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
18000 shares
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
21362000 USD
CY2013Q3 us-gaap Short Term Investments
ShortTermInvestments
43580000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
11300000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4209000 shares
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
97012000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
100657000 USD
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22544000 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25534000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21161000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25407000 shares
fldm Date Of Reincorporation Of Company
DateOfReincorporationOfCompany
2007-07
CY2012Q2 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
1900000 USD
CY2012Q1 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
2300000 USD
CY2013Q1 fldm Expected Milestone Receivable
ExpectedMilestoneReceivable
3200000 USD
CY2012 fldm Line Of Credit Facility Extension Length
LineOfCreditFacilityExtensionLength
P2Y
CY2010Q4 fldm Term Of Contractual Agreement Include Line Of Credit Facility
TermOfContractualAgreementIncludeLineOfCreditFacility
P2Y
fldm Transaction Costs
TransactionCosts
300000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001162194
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25613547 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1999-05-11
dei Entity Registrant Name
EntityRegistrantName
FLUIDIGM CORP
dei Trading Symbol
TradingSymbol
FLDM

Files In Submission

Name View Source Status
0001445305-13-002845-index-headers.html Edgar Link pending
0001445305-13-002845-index.html Edgar Link pending
0001445305-13-002845.txt Edgar Link pending
0001445305-13-002845-xbrl.zip Edgar Link pending
ex-311xq32013form10xq.htm Edgar Link pending
ex-312xq32013form10xq.htm Edgar Link pending
ex-321xq32013form10xq.htm Edgar Link pending
ex-322xq32013form10xq.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fldm-20130930.xml Edgar Link completed
fldm-20130930.xsd Edgar Link pending
fldm-20130930_cal.xml Edgar Link unprocessable
fldm-20130930_def.xml Edgar Link unprocessable
fldm-20130930_lab.xml Edgar Link unprocessable
fldm-20130930_pre.xml Edgar Link unprocessable
q32013form10-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending